Newsletter | October 16, 2026

10.16.26 -- Ditch Paper Binders, Scale Central Labs, And Stay Compliant Across Global Markets

Planning Your Next Rare Disease Study?

With experience across 360+ rare disease studies and 125+ indications, explore how specialized expertise and patient-focused delivery help advance clinical programs.

Request Information

Ergomed Group

Driving Safety And Compliance Seamlessly

Accelerating market entry with the “FSP Country in a Box” solution and maintaining global compliance through expert oversight, scalable, and localized support.

Request Information

IQVIA Safety & Regulatory Compliance

Your IRB, Simplified: Fast, Friendly, And Focused

IRB approval does not have to be defined by delays or confusion. Learn how expert guidance, regulatory support, and modern technology can help research teams move forward.

Request Information

Univo IRB

Eliminate Paper Binders From Your Study

Accelerate trials with a centralized digital workspace that replaces manual documents, boosts collaboration, supports remote access, ensures compliance, and provides real-time visibility.

Request Information

Florence Healthcare

Central Laboratory Solutions

Global clinical trials need central laboratory networks able to scale across countries while keeping biomarker and biospecimen data consistent from one study site to the next.

Request Information

LabConnect

Why Central IRBs Matter For Clinical Trials

Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support. Save time and money while staying fully compliant with regulations.

Request Information

BRANY